Project Details
Description
DESCRIPTION: (adapted from investigator's abstract): This is an application to
study the impact of a cognitive-behavioral hostility-reducing intervention on
autonomic control of the cardiovascular system. It is based on a research
program which explores the relationships among physiological/behavioral
characteristics such as anxiety, hostility, depression, and physical
conditioning, the central and autonomic nervous systems and cardiovascular and
respiratory systems. Considerable evidence, initially anecdotal and in the past
several decades empirical, indicates that hostility and anger are risk factors
for coronary artery disease (CAD). This risk applies not only to patients with
CAD but also to healthy people. Evidence also indicates that hostility is
associated with dysregulation of autonomic period variability (HPV), a
noninvasive index of autonomic regulation of the heart. Moreover, convincing
data demonstrate that low levels of heart period variability confer risk of
recurrent myocardial infarction in patients with CAD and of cardiac morbidity
and mortality in healthy subjects. Finally data demonstrate that cognitive
behavioral treatment (CBT) of hostility and anger is effective in reducing
these negative personality characteristics. Together, these bodies of data
suggest 1) that a mechanism by which hostility promotes the development of CAD
is through the ANS and 2) that a CBT intervention to reduce hostility may
enhance autonomic control of the heart.
In this study, healthy subjects with high levels of hostility, measured by
standard questionnaires, and the interpersonal Hostility Assessment Technique,
will be assigned randomly to a 12-week CBT intervention or a wait-list control
condition. Subjects will be tested of 24-hour levels of HPV and short-term HPV
responses to laboratory challenges prior to the intervention, immediately
following the intervention, and at 6-month follow-up. The investigators will
test the hypothesis that daytime/24 hour HPV will be increased by the CBT
intervention and that the HPV fall in response to laboratory challenge, which
in high hostile subjects is greater than that in controls, will be reduced.
Status | Finished |
---|---|
Effective start/end date | 6/1/00 → 5/31/05 |
Funding
- National Heart, Lung, and Blood Institute: US$464,438.00
- National Heart, Lung, and Blood Institute: US$538,283.00
- National Heart, Lung, and Blood Institute: US$2,160,419.00
- National Heart, Lung, and Blood Institute: US$525,135.00
- National Heart, Lung, and Blood Institute: US$507,163.00
ASJC Scopus Subject Areas
- Cardiology and Cardiovascular Medicine
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.